ESC CVD Risk Calculation 與 Echocardio Notes 使用情況與統計

The ESC CVD Risk Calculation App is designed for healthcare professionals. It provides calculators assessing individual cardiovascular risk. It includes calculators for primary and secondary prevention in various populations: 1. SCORE2 2. SCORE2-OP 3. SCORE2-Diabetes 4. ASCVD 5. SMART 6. SMART-REACH* 7. DIAL* 8. LIFE-CVD* * Available online on U-Prevent (Internet connection required) The ESC CVD Risk Calculation App is available in English. It provides guidance to the most adapted calculator for your patient, and provides an estimation of cardiovascular risk. Of note, patient data are not stored in the App. This application is only for informative use and is not intended to provide therapeutic support or diagnosis assistance. This Application is powered by the European Society of Cardiology (ESC), based upon the source codes of the U-Prevent webtool, a concept developed by University Medical Center Utrecht, redesigned and owned by ORTEC. The SCORE2, SCORE2-OP and SCORE2-Diabetes calculators were developed in collaboration with the ESC Cardiovascular Risk Collaboration unit. The Application has recently been updated in the framework of the EAPC IMPLEMENT Programme (2023) which was supported by Novo Nordisk in the form of an educational grant. The sponsor did not have any involvement or influence on the features nor on the scientific content within the Application.
  • Apple App Store
  • 免費版
  • 醫療

商店排名

- -

Echocardio Notes is a free smartphone and tablet application, designed to provide up-to-date reference values and protocols in echocardiography through a quick, clean and intuitive interface.
  • Apple App Store
  • 免費版
  • 醫療

商店排名

- -

ESC CVD Risk Calculation與 Echocardio Notes 比較排名

比較過去 28 天的 ESC CVD Risk Calculation 排名趨勢與 Echocardio Notes

排名

無可用數據

各國 ESC CVD Risk Calculation vs. Echocardio Notes 排名比較

比較過去 28 天的 ESC CVD Risk Calculation 排名趨勢與 Echocardio Notes

所有類別

無可用數據

使用我們的免費試用版,與所有網站進行比較

立即開始
ESC CVD Risk Calculation VS.
Echocardio Notes

1月 5, 2025